Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ewa Mrukwa-Kominek, Marta Misiuk-Hojlo, Adrienne Csutak, Ingeborg Stalmans & Gerhard Garhofer. (2023) A randomized clinical trial comparing three fixed combinations of bimatoprost with timolol in patients with open-angle glaucoma or ocular hypertension. Current Medical Research and Opinion 39:5, pages 775-783.
Read now
Read now
Nevbahar Tamçelik, Belgin Izgi, Ahmet Temel, Nilgun Yildirim, Mehmet Okka, Altan Özcan, Nurşen Yüksel, Ufuk Elgin, Çiğdem Altan & Baris Ozer. (2017) Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 11, pages 723-731.
Read now
Read now
Stefan Pfennigsdorf, Peter Eschstruth, Stefan Häsemeyer, Cord Feuerhake, Gerrett Brief, Ioana Grobeiu & Andrew Shirlaw. (2016) Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice. Clinical Ophthalmology 10, pages 1837-1846.
Read now
Read now
Stefan Pfennigsdorf, Leo de Jong, Stefan Makk, Yvette Fournichot, Alain Bron, Robert J Morgan-Warren & John Maltman. (2013) A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 7, pages 1219-1225.
Read now
Read now
Articles from other publishers (5)
A. N. Zhuravleva & M. V. Zueva. (2020) Hypotensive glaucoma therapy and neuroprotection. Russian Ophthalmological Journal 13:2, pages 78-82.
Crossref
Crossref
Alfonso García-López, José A Paczka, Jesús Jiménez-Román & Curt Hartleben. (2014) Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study. BMC Ophthalmology 14:1.
Crossref
Crossref
Ivan Goldberg, Rafael Gil Pina, Aitor Lanzagorta-Aresti, Rhett M Schiffman, Charlie Liu & Marina Bejanian. (2014) Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial. British Journal of Ophthalmology 98:7, pages 926-931.
Crossref
Crossref
Italo Giuffre. (2012) Comparative Evaluation of the Efficacy of the Bimatoprost 0.03%, Brimonidine 0.2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0.004%/Timolol 0.5%-Fixed Combinations in Patients Affected by Open-Angle Glaucoma. Open Journal of Ophthalmology 02:04, pages 122-126.
Crossref
Crossref
J.-P. Nordmann & J. Akesbi. (2011) Améliorer l’adhérence au traitement des patients glaucomateux : le rôle du médecin. Journal Français d'Ophtalmologie 34:6, pages 403-408.
Crossref
Crossref